Corbus Pharmaceuticals Holdings Inc (CRBP)
17.87
-0.11
(-0.61%)
USD |
NASDAQ |
Nov 27, 15:32
Corbus Pharmaceuticals Holdings Total Assets (Quarterly): 164.17M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 164.17M |
| June 30, 2024 | 151.98M |
| March 31, 2024 | 125.74M |
| December 31, 2023 | 28.27M |
| September 30, 2023 | 36.28M |
| June 30, 2023 | 43.72M |
| March 31, 2023 | 51.65M |
| December 31, 2022 | 66.31M |
| September 30, 2022 | 73.83M |
| June 30, 2022 | 82.07M |
| March 31, 2022 | 95.68M |
| December 31, 2021 | 107.73M |
| September 30, 2021 | 119.57M |
| June 30, 2021 | 120.61M |
| March 31, 2021 | 140.14M |
| December 31, 2020 | 102.29M |
| September 30, 2020 | 95.84M |
| June 30, 2020 | 98.12M |
| March 31, 2020 | 65.20M |
| December 31, 2019 | 49.14M |
| September 30, 2019 | 68.13M |
| Date | Value |
|---|---|
| June 30, 2019 | 84.12M |
| March 31, 2019 | 101.39M |
| December 31, 2018 | 46.99M |
| September 30, 2018 | 61.18M |
| June 30, 2018 | 70.29M |
| March 31, 2018 | 77.14M |
| December 31, 2017 | 66.98M |
| September 30, 2017 | 38.42M |
| June 30, 2017 | 44.56M |
| March 31, 2017 | 50.61M |
| December 31, 2016 | 17.89M |
| September 30, 2016 | 19.76M |
| June 30, 2016 | 22.63M |
| March 31, 2016 | 10.50M |
| December 31, 2015 | 12.88M |
| September 30, 2015 | 13.33M |
| June 30, 2015 | 9.565M |
| March 31, 2015 | 5.246M |
| December 31, 2014 | 6.601M |
| September 30, 2014 | 7.630M |
| December 31, 2013 | 0.3055M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
28.27M
Minimum
Dec 2023
164.17M
Maximum
Sep 2024
90.92M
Average
95.76M
Median
Total Assets (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 13.59M |
| Perspective Therapeutics Inc | 391.15M |
| Protalix BioTherapeutics Inc | 61.56M |
| Electromed Inc | 48.92M |
| Armata Pharmaceuticals Inc | 98.24M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 13.67M |
| Shareholders Equity (Quarterly) | 150.50M |